As of 30 Sep 2025, 1 institutional investors reported holding 22,793 shares of Genmab A/S - Common Stock - Foreign.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 22,793 | $6,909,903 | +$304,675 | $303.16 | 1 |
| 2025 Q2 | 21,788 | $4,523,579 | +$774,000 | $207.62 | 1 |
| 2025 Q1 | 18,060 | $3,507,482 | -$937,754 | $194.21 | 1 |
| 2024 Q4 | 22,712 | $4,708,350 | +$4,705,862 | $207.28 | 2 |
| 2024 Q3 | 12 | $2,903 | +$968 | $241.92 | 1 |
| 2024 Q2 | 8 | $2,005 | $0 | $250.62 | 1 |
| 2024 Q1 | 8 | $2,411 | +$2,411 | $301.38 | 1 |
| 2023 Q4 | 0 | $0 | -$24,926 | $303.16 | 0 |
| 2023 Q3 | 70 | $24,926 | +$24,926 | $356.09 | 1 |
| 2021 Q1 | 0 | $0 | -$1,238,889 | $303.16 | 0 |
| 2020 Q4 | 3,060 | $1,238,889 | $0 | $404.87 | 1 |
| 2020 Q3 | 3,060 | $1,108,739 | +$39,857 | $362.33 | 1 |
| 2020 Q2 | 2,950 | $986,897 | $0 | $334.54 | 1 |
| 2020 Q1 | 2,950 | $597,305 | +$597,305 | $202.48 | 1 |